Overview

Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

Status:
Completed

Trial end date:
2006-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to find out if androgen deprivation therapy affects insulin, cardiac risk factors such as cholesterol level, and body fat and muscle.

Details

Lead Sponsor:

Massachusetts General Hospital

Collaborators:

Brigham and Women's Hospital
Dana-Farber Cancer Institute

Treatments:

Androgens
Ascorbic Acid
Estrogens, Conjugated (USP)
Insulin
Methyltestosterone